Does Gender Impact Intensity of Care Provided to Older Medical Intensive Care Unit Patients? by Akgün, Kathleen M. et al.
Hindawi Publishing Corporation
Critical Care Research and Practice
Volume 2010, Article ID 404608, 8 pages
doi:10.1155/2010/404608
Research Article
DoesGenderImpact Intensity of Care Provided to
OlderMedical Intensive Care Unit Patients?
Kathleen M. Akg¨ un,1 Terrence E. Murphy,2 KatyL.B. Araujo,2 PeterH.Van Ness,2,3
andMargaretPisani1
1Pulmonary & Critical Care Section, Department of Internal Medicine, Yale University School of Medicine,
333 Cedar Street P.O. Box 208057, New Haven, CT 06520-8057, USA
2Geriatrics Section, and the Program on Aging, Department of Internal Medicine, Yale University School of Medicine,
New Haven, CT 06520-8057, USA
3Division of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT 06520-8057, USA
Correspondence should be addressed to Kathleen M. Akg¨ un, kathleen.akgun@yale.edu
Received 4 December 2009; Accepted 19 September 2010
Academic Editor: J. L. Vincent
Copyright © 2010 Kathleen M. Akg¨ un et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Introduction.Womenreceivelessaggressivecriticalcarethanmenbasedonpriorstudies.Nodocumentedstudiesevaluatewhether
men and women are treated equally in the medical intensive care unit (MICU). The Therapeutic Intervention Scoring System-
28 (TISS-28) has been used to examine gender diﬀerences in mixed ICU studies. However, it has not been used to evaluate
equivalence of care in older MICU patients. We hypothesize that given nonsigniﬁcant, baseline health diﬀerences between genders
at MICU admission, the level of care provided would be equivalent. Methods. Prospective cohort of 309 patients ≥60 years old
in the MICU of an urban university teaching hospital. Explanatory variables were demographic data and baseline measures.
Primary outcomes were TISS-28 scores and MICU interventions. We compare TISS-28 scores by gender using a statistical test
of equivalence. Results. Women were older and had more chronic respiratory failure at MICU admission. Using equivalence limits
of ±15% on gender-based scores of TISS-28, MICU interventions were equivalent. Supplementary analysis showed no statistically
signiﬁcant association between gender and mortality. Conclusions. In contrast with other reports from the cardiac critical care
literature, as measured by the TISS-28, gender-based care delivered to older MICU patients in this cohort was equivalent.
1.Introduction
Currently12.6%ofthetotalpopulationintheU.S.is65years
of age or older [1]. This number is expected to increase to
16% by 2020. Within the 65 and older age group, 58% are
women [1]. As the population ages, medical intensive care
unit (MICU) utilization is likely to increase. Prior studies
investigating aging and critical illness show that MICU
outcomes are primarily determined by severity of illness and
respiratory failure rather than age [2–4].
Initial studies examining gender diﬀerences in the ICU
were conducted with cardiac patients. These studies demon-
strated that women were older and sicker at the time of
angioplasty or surgical bypass, receive fewer invasive pro-
cedures, such as implantable cardioverter deﬁbrillators and
heart transplants, and were less likely to receive appropriate
medications during and after non-ST segment elevation
myocardial infarctions [5]. These ﬁndings suggest potential
treatmentdisparitiesbetweenmenandwomen.However,the
importance of gender for MICU outcomes in older patients
has not been fully established [2–4, 6, 7].
Severity of illness scores such as the Acute Physiology
and Chronic Health Evaluation (APACHE II), Sequential
Organ Failure Assessment (SOFA), and the Simpliﬁed Acute
Physiology Score (SAPS II) are useful descriptors for patient
acuity and predictors of mortality but do not account for
the patient care-related workload required for ICU patients.
The Therapeutic Intervention Scoring System-28 (TISS-28)
is a simple, reliable tool for describing both the severity of
illness and the intensity of nursing care delivered to ICU2 Critical Care Research and Practice
patients [8, 9]. The TISS-28 has been used extensively in
older ICU populations, exhibiting negative correlation with
age, particularly in patients older than 85 years [10].
Whether there are gender diﬀerences in intensity of
care delivered to older MICU patients using the TISS-28
has not been investigated. This study sought to determine
whether there were diﬀerences in provision of MICU care
and outcomes according to gender in an older cohort of
patients. We also examined factors at MICU admission and
during the course of the MICU stay according to gender. We
hypothesized that if there were minimal or no diﬀerences
in baseline health status of men and women upon MICU
admission, then care provided to men and women in our
MICU would be equivalent. This study is novel in using
a validated scoring system (TISS-28) to formally test for
statistical equivalence of MICU care between older men and
women.
2.MaterialsandMethods
2.1. Participants and Setting. The study was a prospective
cohort of 309 patients aged 60 years and older in the medical
intensive care unit of Yale-New Haven Hospital (YNHH),
who were enrolled from September 5, 2002 to September 30,
2004. YNHH is a 900-bed urban teaching hospital with a 14-
bed medical ICU (MICU) serving a large urban community
as well as a referral population. Patients were excluded if
there was no identiﬁable proxy to provide information about
the patient, if they were transferred from another hospital or
ICU, or if the patients died before the proxy was identiﬁed.
Informed consent for participation was obtained from the
proxy and patients according to procedures approved by
the Institutional Review Board of Yale University School of
Medicine.
2.2. Study Procedures
2.2.1. Proxy Interviews. As previously described, proxy
respondents were the primary sources of baseline infor-
mation due to critical illness [11–14]. Information on
premorbid functional and cognitive status was obtained.
2.2.2. Patient Factors. Charts were reviewed at the time
of enrollment to obtain demographic information, admis-
sion diagnosis, preexisting depression, medication use at
admission, and the Charlson Comorbidity Index (CCI) [15].
SeverityofillnesswasassessedwiththeAcutePhysiologyand
Chronic Health Evaluation II Score (APACHE II) [16].
2.2.3. ICU and Hospital Factors. Use of MICU interven-
tions such as mechanical ventilation, vasopressors, new
onset dialysis, and pulmonary artery catheterization were
recorded. Total number of days in the MICU and requiring
mechanical ventilation were recorded to calculate median
values. The full range of days in the MICU or on mechanical
ventilation for the entire cohort was measured. Patients were
assessed daily for delirium. Changes in resuscitation status
during the MICU admission were documented. Continuous
sedativeandnarcoticdrugadministrationweretrackedusing
Infusion Administration Pumps which record total dose
delivered to the patient.
2.2.4. TISS-28. The TISS-28 is a simple, validated scoring
system designed to quantify severity of patient illness
and therapeutic activities in the ICU in terms of nursing
workload [9]. TISS-28 scores range from 1 to 78 points.
Each TISS-28 point correlates with 10.6 minutes of nursing
care [9]. The TISS-28 score is compiled from seven general
groups: Basic Activities (dressing changes, laboratory blood
draws, single medication administration, etc.), Ventilatory
Support (mechanical ventilation, care of airway, intratra-
cheal suctioning, etc.), Cardiovascular Support (arterial
lines, central venous lines, vasoactive medications, intra-
venous ﬂuid resuscitation, etc.), Renal Support (active diure-
sis, quantitative urine output, dialysis), Neurologic Support
(measurement of intracranial pressures), Metabolic Support
(treatment of complicated metabolic acidosis or alkalosis,
enteral feeding, intravenous hyperalimentation), and Spe-
ciﬁcInterventions(pacemakers,cardioversions,endoscopies,
emergencies surgeries, etc.).
For this study, the information for the TISS-28 was
collected prospectively from the nurses’ bedside ﬂow sheet
and the medical record. Data from the entire MICU stay,
ranging from admission through discharge, were utilized in
the calculation. For patients who died during their MICU
stay, the TISS-28 was calculated to include all interventions
through time of death.
2.3.Outcomes. Weexaminedgenderdiﬀerencesatthreetime
points. We compared baseline factors at MICU admission,
interventions during the MICU stay including the TISS-
28 scores and outcomes including mortality and length of
stay. Fifteen-month mortality was determined by follow-up
telephone interview.
2.4. Statistical Analysis. Admission characteristics stratiﬁed
by gender were summarized with means and standard devi-
ations or medians and interquartile ranges for continuous
variables, and with counts and percentages for dichotomous
variables. Tests for baseline gender diﬀerences were made
using t-tests or Wilcoxon rank sum tests for continuous
variables and Pearson chi-square or Fisher’s exact test for
dichotomous variables. For these tests the null hypotheses
assumed equality of admission characteristics for men and
women.
When comparing two groups, a lack of statistical
diﬀerence is a diﬀerent conclusion than saying that two
groups received the same treatment, the latter a much less
stringent test. We wanted to evaluate if treatment between
men and women was the same using a formal test of
statisticalequivalence.Anonparametric, Mann-Whitney test
of equivalence for discrete distributions was used to compare
the TISS-28 scores between men and women during their
stay in the MICU. The null hypothesis in this case was
that men and women received diﬀerent amounts of overall
critical care. We chose equivalence limits of ±15% to reﬂect
the percentile diﬀerences around the median value on theCritical Care Research and Practice 3
Table 1: ICU admission characteristics of patients enrolled in study (N = 309)
∗.
Characteristic Men (n = 145) Women (n = 164) P value
Age in years, Mean (SD) 73.7 (8.2) 75.6 (8.6) .046
Nonwhite race 19 (13) 32 (20) .13
Medicaid status 13 (9) 30 (18) .02
APACHE II Score 23.1 (6.6) 23.8 (6.2) .36
Admitted from home 117 (81) 124 (76) .28
Baseline Medical Status
Body Mass Index (BMI, m2/kg), Mean (SD)† 25.7 (6.9) 26.1 (9.8) .88
Chronic respiratory failure 37 (25) 64 (39) .01
Chronic heart failure 33 (23) 44 (27) .41
Chronic renal insuﬃciency 28 (19) 28 (17) .61
Hepatic Failure 1 (<1) 1 (<1) 1.0
Malignancy 10 (7) 8 (5) .45
Depression 31 (21) 54 (33) .02
Dementia† 42 (29) 53 (33) .55
Antidepressants prior to ICU admission 28 (19) 49 (30) .03
Any Impairment in Activities of Daily Living 50 (34) 61 (37) .62
Any Impairment in Activities of Instrumental Daily Living 120 (83) 144 (88) .21
Full Code on ICU Admission† 121 (83) 144 (88) .27
Admitting Diagnosis
Sepsis 23 (16) 28 (17) .77
Respiratory 68 (47) 88 (54) .23
Neurologic 1 (<1) 4 (2) .38
Gastrointestinal hemorrhage 33 (23) 19 (12) .009
Other 20 (14) 25 (15) .72
∗All variables presented as n (%) except where indicated. †Missing data present for some subjects. For BMI missing = 9; Dementia missing = 3; Code status
missing = 1.
TISS-28 scale that we regard as being clinically equivalent
based on clinical experience with critical care for older
persons in the MICU. These equivalence limits correspond
to an approximate change of ±5 points between the median
TISS values of the gender subgroups. Because 4 points are
assignedtointubation,achangeof5pointsatthegrouplevel
would reﬂect even larger treatment diﬀerences “on average”
between individual men and women.
The equivalence test was performed using the SAS
macro “mwtie xy” written by Wellek [17]w i t hP ≤ .05
indicating statistical signiﬁcance. In supplementary analysis
we examined time to death within 15 months of MICU
admission with a Cox proportional hazards multivariable
model [18] that included covariates for age, APACHE II
at admission, gender, TISS-28, and the interaction between
gender and TISS-28. These covariates were chosen based on
prior ICU studies reporting that mortality is most closely
tied to APACHE II scores. Given that the TISS-28 and
the interaction between the TISS-28 and gender were the
primary outcomes of interest and that the TISS-28 correlates
with risk of death, these were additional covariates chosen.
All statistical tests were two tailed, with P<. 05 indicating
signiﬁcance. Analysis was performed with SAS version 9.1.3
software [19, 20].
3. Results
3.1. Comparisons between Men and Women Admitted to the
MICU. In this older MICU cohort, women were older than
men (75.6 years versus 73.7 years; P = .046), were more
frequently enrolled in Medicaid (18% versus 9%; P = .02),
and had more preexisting chronic respiratory failure (39%
versus 25%; P = .01). More men were admitted with
gastrointestinal hemorrhage than women (23% versus 12%,
P = .008). Women were more likely than men to have
a diagnosis of depression and to be taking antidepressants
prior to admission to the ICU (30% versus 19%; P = .03).
However, there were no signiﬁcant diﬀerences between men
and women regarding APACHE II scoreon MICU admission
or “Do Not Resuscitate (DNR)” or “Do Not Intubate (DNI)”
orders.Additionalresultsregardingadmissioncharacteristics
for men and women enrolled are included in Table 1.T h e r e
were also no statistical diﬀerences in ICU interventions such
as intubation, days of intubation, or ICU length of stay
between men and women (Table 2).
3.2. TISS-28 Scores, APACHE II Scores and MICU Mortal-
ity. The amount of critical care delivered to women was
equivalent to men based on their respective TISS-28 scores.4 Critical Care Research and Practice
Table 2: Factors related to time in ICU (N = 309).
Continuous Descriptors of ICU Stay
Men (n = 145) Women (n = 164) P value∗
Median (IQR) Median (IQR)
Therapeutic Intervention Score (TISS-28)
Range: 9–50
25 (14) 26 (14) Equivalent at P ≤ .05
∗∗∗∗
Days of stay in ICU (LOS)
∗∗
Range: 1–51
4 (5) 4.5 (4.5) .38
Days of Intubation in ICU
Range: 1–48
6 (8) 5 (6) .69
Men (n = 145) Women (n = 164) P value∗
n (%) n (%)
ICU Mortality 20 (14) 33 (20) .14
ICU Delirium 110 (77) 129 (80) .50
ICU readmission 13 (9) 16 (10) .81
Intubation 78 (54) 89 (54) .93
Use of vasopressor medications (Dopamine,
dobutamine, norepinephrine,
epinephrine, phenylephrine, vasopressin)
54 (17) 77 (25) .0848
Tracheostomy 8 (5) 7 (4) .61
Continuous Positive Airway Pressure (CPAP)
or BiLevel Positive Airway Pressure (BiPAP)
30 (21) 42 (26) .31
P u l m o n a r yA r t e r yC a t h e t e r i z a t i o n 10 (7) 19 (12) .16
Enteral Nutrition (Nasogastric Tube or
Percutaneous Endoscopic Gastrostomy Tube)
53 (37) 60 (37) .99
Hemodialysis 7 (5) 10 (6) .62
Continuous Veno-Venous Hemoﬁltration
(CVVH)
5 (3) 8 (5) .53
Change in code status to “Less aggressive” 37 (26) 45 (27) .70
†Missing data present for some subjects. For ICU delirium missing = 5.
∗Chi-square tests for categorical variables and Wilcoxon rank sum tests for continuous variables were used with statistical signiﬁcance deﬁned as P value ≤
.05.
∗∗Length of stay was for ﬁrst admission.
∗∗∗Delirium was deﬁned by either positive ICU Confusion Assessment Method (CAM) or chart indication of delirium during ICU stay.
∗∗∗∗A nonparametric test of equivalence rejects the null hypothesis that men and women are not equivalent at signiﬁcance level 0.05 for equivalence limits
of ±15% around median value. IQR (Interquartile Range, i.e., central ﬁfty percent distribution).
The statistical test of equivalence employed equivalence
limits of ±15 percent around the cohort’s median value
of TISS-28 scores. Additionally, there was no evidence of
statistically signiﬁcant diﬀerences between men and women
in rates of speciﬁc MICU interventions such as intubation,
tracheostomy, renal replacement therapy, or change in code
status to “Less aggressive”. Table 2 compares selected speciﬁc
components of the TISS-28 scores related to patients in the
MICUbygender.TISS-28scoressigniﬁcantlycorrelatedwith
APACHEIIscores(KendallTauB0.27311 (<0.0001)andrisk
of death in the MICU (Kendall Tau B 0.26377 (<0.0001).
There was no evidence of gender-based diﬀerences in
medication administration, or MICU or hospital length of
stay.
We also examined TISS-28 scores by age category. The
median (range) TISS-28 scores for patients age 60–69 (n =
87) was 27 (9–50), for patients age 70–79 (n = 124) was 25
(9–43) and for patients age 80 (n = 98) and older was 23
(9–46).
3.3. Patient Discharge and Fifteen-Month Mortality. In sup-
plementary analysis women were less likely to be discharged
home(42%versus52%;P = .13)althoughthediﬀerencewas
notstatisticallysigniﬁcant.Therewasnoassociationbetween
gender and mortality up to 15 months after ICU admission.
There was also no association between 15-month mortality
and the interaction of gender and TISS score (Table 3).
4. Discussion
While gender diﬀerences in ICU care delivered have been
reported in the cardiac critical care literature and some
mixed medical and surgical ICUs, we did not detect any
evidence of gender-based diﬀerences in rates of MICU
interventions when looking at speciﬁc aspects of critical care.
In addition, there was no evidence of statistically signiﬁcant
gender-based diﬀerences in administration of medications
in the MICU. After controlling for age and severity of
illness, there was no evidence of a statistically signiﬁcantCritical Care Research and Practice 5
Table 3: Mortality and discharge disposition (N = 309).
Men (n = 145) Women (n = 164) P value
n (%) n (%)
Death (ICU or Floor) 32 (22) 47 (29) .17
Overall Mortality (15 months from ICU
admission)
86 (59) 85 (52) .76
∗
Discharge to skilled nursing facility, assisted
living, rehabilitation unit, hospice,
hospital
∗∗
54 (48) 67 (58) .13
Chi-square or Fisher’s exact tests were used for categorical variables with statistical signiﬁcance deﬁned as P value ≤ .05.
∗The P value reported pertains to the interaction term in a Cox proportional hazards multivariable model including age, APS at admission, gender, TISS-28,
and the interaction between gender and TISS-28.
∗∗Those not discharged to Skilled Nursing Facility, and so forth were discharged to home or friend/relative.
Missing data are present for some subjects. For discharge location missing = 1.
diﬀerence in ICU or 15-month mortality between men and
women.
Men admitted to the MICU were younger than women,
likely related to increased longevity in women in the general
population. Additional diﬀerences between men and women
on MICU admission included receipt of Medicaid, chronic
respiratory failure and admission diagnosis of gastrointesti-
nal bleed. Given these minimal diﬀerences between men and
womenonMICUadmission,ourconditionalhypothesisthat
there would be equivalent care delivered to men and women
if there were minimal baseline diﬀerences was supported by
these study results.
Our study showed that women were more likely to
have underlying chronic pulmonary disease compared to
men. With increasing rates of women smoking, there
has been a shift towards more women than men dying
from chronic obstructive pulmonary disease (COPD) [21].
Men were more likely to be admitted with gastrointestinal
hemorrhage in our cohort. This ﬁnding conforms to data
that demonstrates male gender is associated with increased
risk factors for gastrointestinal hemorrhage, including peptic
ulcerdisease,colonicpolyps,orgastrointestinalmalignancies
[22–25].
In our study, the average TISS-28 score in our older
MICU population was 25 for men and 26 for women which
is consistent with the range of TISS-28 scores from other
studies. In a study of mixed medical and surgical ICUs in
Brazil, the average TISS-28 for all patients who stayed in
the ICU for at least 24 hours was 23 with a range from
14–32 [26]. The majority of these patients were admitted
to surgical ICUs. Mean TISS-28 scores in prior studies of
predominantly medical ICUs range between 22–33.8 [27–
29]. TISS-28 scores and in-hospital mortality have shown a
p o s i t i v ec o r r e l a t i o ni np a t i e n t so l d e rt h a n6 5y e a r so fa g e
[30]; our study also found a positive correlation between
TISS-28scoresandAPACHEIIscores(KendallTauB0.27311
(<0.0001) and mortality (ICU, Kendall Tau B: 0.26377
(<0.0001). Older patients may be more vulnerable to poor
ICU outcomes if they receive less aggressive care despite a
greater severity of illness [31].
The current study shows that the care delivered to
older men and women as measured by the TISS-28 was
equivalent in our MICU. Treatment disparities between men
and women have been observed in other studies of critically
ill patients and may impact outcomes according to level of
aggressive care [5, 29, 32]. A large Belgian study of mixed
medical and surgical ICU patients showed that women had
a higher mortality than men, particularly women greater
than 50 years old during their ﬁrst days of ICU admission
[33]; however, this study did not adjust for severity of illness.
Another study examining gender diﬀerence in acute myocar-
dial infarction found that while there were no diﬀerences
in diagnostic or treatment procedures between men and
women, female sex was an independent predictor for adverse
events including reinfarction, death, in-patient stroke, and
postinfarction angina [34].
Conversely, in a single-site study of a surgical ICU by
Wichmann et al. where less women were referred for care
in the ICU, there was no diﬀerence in mortality between
men and women who were admitted to the surgical ICU
[35]. A large Finnish study of surgical and medical ICUs
found that men had a modest but signiﬁcantly higher TISS-
28 score [29]. Despite this, older men had an increased risk
of death after adjusting for severity of illness. In the medical
subgroup, there was no diﬀerence in mortality between
men and women [29]. In another study of critically ill
medical and surgical patients from Austria, men received
more invasive procedures such as mechanical ventilation,
renal replacement therapy, and vasoactive medications than
womenalthoughwomenhadagreaterseverityofillness[32].
These diﬀerences were observed in all age groups but were
most pronounced in the older population (age 61–80 years).
Even with the observed diﬀerences in level of care between
men and women, there were no diﬀerences in outcomes or
mortality between men and women in multivariate analysis
[32].
While studies show equivalent or greater intensive care
administered to men, other data suggests that neurohumoral
changes in men may have greater adverse eﬀects on their
survival after critical illness. Testosterone has immunosup-
pressive characteristics with detrimental eﬀectsaftertrauma-
hemorrhage injury in animal models, increasing susceptibil-
itytoinfectionsorsepsis[35–37].Menwithsevereinfections
haveelevated17β-estradiolandprogesteronelevelswhichare6 Critical Care Research and Practice
associated with increased mortality [38]. Similarly, women
with severe infections had higher levels of 17β-estradiol
and testosterone which were also associated with higher
mortality[38].Inadditiontomaleandfemalesexhormones,
biomarkers such as tumor necrosis factor, interleukin-10,
andinterleukin-6arepostulatedtoplayaroleinthesegender
disparities.
The main limitation of this study is that it was performed
in a single ICU in a large academic medical center so
results may not be representative of care provided in other
subspecialty ICUs or in community hospitals. Another
limitation of this study is that the TISS-28 does not account
for patient preferences and acceptable levels of intensive
care. In addition, the TISS scoring systems were derived to
measure ICU nursing activities which may not fully correlate
with aggressiveness of ICU care. Strengths include the large
samplesizeofolderICUpatientswithequalnumbersofmen
and woman along with the high participation. In addition,
we collected a detailed, clinically rich prospective data set
using validated instruments.
In summary, this study is novel in demonstrating that
treatment of men and women in this ICU cohort is not only
not diﬀerent but is statistically equivalent using equivalence
limits based on clinical experience in caring for older MICU
patients.Finally,therewasnodiﬀerenceinmortalitybetween
men and women in this cohort.
5. Conclusions
In contrast with prior studies, men and women in this older
MICU cohort with similar baseline characteristics on MICU
admission received equivalent critical care based on their
TISS-28 scores. In this study, MICU and 15-month mortality
were also similar between men and women. As the U.S.
population ages and medical technology advances, there will
be greater need and opportunity for interventions in medical
ICUs. It will be valuable to use reliable measurements for
the amount of care provided and weigh their impact on
ICU survival. While our study did not show signiﬁcant
diﬀerences in MICU care or 15-month mortality between
men and women, gender-based treatments and mortality
should continue to be examined for biological diﬀerences
between men and women, patient and cultural inﬂuences,
and biases in clinician practice. Future studies will be
necessary to further examine gender diﬀerences in critically
ill patients.
Key Messages
(i) In this cohort of older patients admitted to a medical
intensive care unit (MICU), women were older than
men and had more chronic respiratory disease but
had otherwise similar baseline characteristics.
(ii) Men and women in this older cohort received equiv-
alent care in the MICU based on the Therapeutic
Intervention Scoring System-28 (TISS-28).
(iii) After adjusting for age and severity of illness, there
was no diﬀerence in MICU or 15-month mortality.
(iv) Contrary to prior studies in cardiac ICUs and mixed
ICUs, there was no evidence of gender disparity
impactingtheamountofcriticalcaredeliveredtothis
cohort of older patients.
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